Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Explained - Why Jefferies is bearish on Dr. Reddy's and Cipla but bullish on Mankind Pharma
Jefferies has mixed views on pharma stocks. It has an "underperform" rating on Dr Reddy's and Cipla, and a "buy" recommendation on Mankind Pharma.
Stock Picks Today: HDFC AMC, Trent, Titan, Mankind Pharma And More On Brokerages' Radar
Check out top stocks under brokerages' radar heading into trade today.
Mankind Pharma partners Denovo Sciences for AI-led drug discovery
Mankind Pharma has partnered with Denovo Sciences to accelerate drug discovery using artificial intelligence. This collaboration aims to significantly cut down early research timelines, enhance the quality of potential drug candidates, and ensure only the most promising ones advance. By combining Mankind Pharma's R&D prowess with Denovo's AI platform, the companies expect to bring effective and accessible treatments to patients faster, marking a significant step in innovation-driven research.
Mankind Pharma joins hands with Denovo Sciences for AI-powered drug discovery
Mankind Pharma has joined forces with Denovo Sciences to revolutionize drug discovery using artificial intelligence. This strategic partnership aims to significantly shorten development timelines, improve the quality of potential drug candidates, and identify the most promising options. By integrating AI with human expertise, the companies are set to accelerate the delivery of effective and accessible new medicines to patients, marking a significant step forward in pharmaceutical innovation.
Five Stocks To Buy: Eternal, Trent, Eicher Motors And More | June 22, 2026
Top picks for Monday, June 22, include food-delivery platform Eternal, retail major Trent, automotive heavyweight Eicher Motors, PSU lender Union Bank of India, and pharmaceutical player Mankind Pharma.
Urban Harvest in talks to raise ₹300 crore at ₹1,500 crore valuation
The round is expected to include existing investors such as Info Edge, the family office of Mankind Pharma, and angel investor Sandeep Kapadia, among others.
Bernstein backs Zydus, Lupin and Sun Pharma on innovation shift
Nandan Kulkarni, Director–India Healthcare & Senior Research Analyst at Bernstein, sees strong opportunities in CDMOs, specialty therapies, biosimilars and licensing deals. While favouring Zydus, Lupin and Sun Pharma, he remains cautious on Biocon and Mankind Pharma, and argues that India's shift from generics to innovation could drive the next phase of growth for the pharma industry.
Stock Picks Today: Adani Ports, Hindalco, Mankind Pharma, Minda Corp, L&T On Brokerages' Radar
Check out top stocks under brokerages' radar heading into trade today.
Ipca Laboratories among 5 stocks showing bullish RSI upswing
Five Nifty500 stocks, including Leela Palaces, Eris Lifesciences, Indian Bank, Mankind Pharma, and Ipca Laboratories, showed bullish momentum as their RSI crossed above 50, signaling potential upward price movement.
Stock Picks Today: Adani Ports, Hindalco, JSW Steel, Mankind Pharma, LTIM And More On Brokerages' Radar
Check out top stocks under brokerages' radar heading into trade today.
Mankind Pharma Ltd eases for fifth straight session
Mankind Pharma Ltd is quoting at Rs 2412.2, down 0.47% on the day as on 13:19 IST on the NSE. The stock tumbled 2.88% in last one year as compared to a 3.49% slide in NIFTY and a 15.46% spurt in the Nifty Pharma index.
Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?
Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pharma index rebounded from early losses to rise nearly 1%, crossing the 25,000 mark and hitting a fresh 52-week high of 25,043.